Aclaris Therapeutics
Develops immunology drug candidates through biologics, kinase inhibitors, and discovery services.
$6.01
After-hours close0.00 (0.00%)
At close$6.01(−2.44%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.17 | — | — |
| Aug 2026 | −$0.16 | −$0.15 | +6.3% |
| May 2026 | −$0.16 | −$0.15 | +6.3% |
| Feb 2026 | −$0.15 | −$0.16 | −6.7% |
| Nov 2025 | −$0.13 | −$0.12 | +7.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Oct 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.17 | — | — | $1.3M | — | — |
| Aug 6, 2026 | −$0.16 | −$0.15 | +6.3% | $1.4M | $1.6M | +17.8% |
| May 7, 2026 | −$0.16 | −$0.15 | +6.3% | $1.3M | $2.0M | +51.0% |
| Feb 26, 2026 | −$0.15 | −$0.16 | −6.7% | $2.1M | $1.3M | −37.5% |
| Nov 6, 2025 | −$0.13 | −$0.12 | +7.7% | $2.1M | $3.3M | +59.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 23, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 10, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 2, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 7, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Aug 7, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 25, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 8, 2019 | ||||||
| Mar 18, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 3, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 12, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 9, 2017 | ||||||
| Mar 15, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 11, 2016 | ||||||
| May 11, 2016 | ||||||
| Mar 23, 2016 | ||||||
| Nov 18, 2015 | ||||||
| Oct 13, 2015 | ||||||